Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 3
1994 2
1995 4
1996 2
1997 2
1998 4
1999 5
2000 8
2001 6
2002 8
2003 14
2004 12
2005 13
2006 25
2007 32
2008 15
2009 20
2010 21
2011 24
2012 33
2013 29
2014 31
2015 22
2016 18
2017 17
2018 15
2019 20
2020 13
2021 11
2022 15
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

407 results

Results by year

Filters applied: . Clear all
Page 1
Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients.
Willeit P, Tschiderer L, Allara E, Reuber K, Seekircher L, Gao L, Liao X, Lonn E, Gerstein HC, Yusuf S, Brouwers FP, Asselbergs FW, van Gilst W, Anderssen SA, Grobbee DE, Kastelein JJP, Visseren FLJ, Ntaios G, Hatzitolios AI, Savopoulos C, Nieuwkerk PT, Stroes E, Walters M, Higgins P, Dawson J, Gresele P, Guglielmini G, Migliacci R, Ezhov M, Safarova M, Balakhonova T, Sato E, Amaha M, Nakamura T, Kapellas K, Jamieson LM, Skilton M, Blumenthal JA, Hinderliter A, Sherwood A, Smith PJ, van Agtmael MA, Reiss P, van Vonderen MGA, Kiechl S, Klingenschmid G, Sitzer M, Stehouwer CDA, Uthoff H, Zou ZY, Cunha AR, Neves MF, Witham MD, Park HW, Lee MS, Bae JH, Bernal E, Wachtell K, Kjeldsen SE, Olsen MH, Preiss D, Sattar N, Beishuizen E, Huisman MV, Espeland MA, Schmidt C, Agewall S, Ok E, Aşçi G, de Groot E, Grooteman MPC, Blankestijn PJ, Bots ML, Sweeting MJ, Thompson SG, Lorenz MW; PROG-IMT and the Proof-ATHERO Study Groups. Willeit P, et al. Circulation. 2020 Aug 18;142(7):621-642. doi: 10.1161/CIRCULATIONAHA.120.046361. Epub 2020 Jun 17. Circulation. 2020. PMID: 32546049 Free PMC article.
BACKGROUND: To quantify the association between effects of interventions on carotid intima-media thickness (cIMT) progression and their effects on cardiovascular disease (CVD) risk. ...The primary outcome was a combined CVD end point defined as myoc …
BACKGROUND: To quantify the association between effects of interventions on carotid intima-media thickness (cIMT) progr …
Carotid Intima-Media Thickness as a Cardiovascular Risk Factor and Imaging Pathway of Atherosclerosis.
Centurión OA. Centurión OA. Crit Pathw Cardiol. 2016 Dec;15(4):152-160. doi: 10.1097/HPC.0000000000000087. Crit Pathw Cardiol. 2016. PMID: 27846007 Review.
Assessment of carotid intima-media thickness (IMT) has emerged as a simple and noninvasive technique for measuring atherosclerotic burden. ...The utilization of carotid IMT measurements as a surrogate end point in clinical trials evaluating a specific drug in …
Assessment of carotid intima-media thickness (IMT) has emerged as a simple and noninvasive technique for measuring athe …
Carotid intima-media thickness for cardiovascular risk assessment: systematic review and meta-analysis.
van den Oord SC, Sijbrands EJ, ten Kate GL, van Klaveren D, van Domburg RT, van der Steen AF, Schinkel AF. van den Oord SC, et al. Atherosclerosis. 2013 May;228(1):1-11. doi: 10.1016/j.atherosclerosis.2013.01.025. Epub 2013 Jan 25. Atherosclerosis. 2013. PMID: 23395523 Review.
OBJECTIVE: B-mode ultrasound measurement of the carotid intima-media thickness (CIMT) is a widely used marker for atherosclerosis and is associated with future cardiovascular events. ...A 0.1 mm increase in CIMT was predictive for myocardial …
OBJECTIVE: B-mode ultrasound measurement of the carotid intima-media thickness (CIMT) is a widely used marker for at …
Atherosclerosis and cardiovascular involvement in celiac disease: the role of autoimmunity and inflammation.
Santoro L, De Matteis G, Fuorlo M, Giupponi B, Martone AM, Landi F, Landolfi R, Santoliquido A. Santoro L, et al. Eur Rev Med Pharmacol Sci. 2017 Dec;21(23):5437-5444. doi: 10.26355/eurrev_201712_13932. Eur Rev Med Pharmacol Sci. 2017. PMID: 29243787 Free article. Review.
OBJECTIVE: The aim of this review is to explore the evidence about the association among celiac disease (CD), atherosclerosis (AS) and cardiovascular (CV) diseases, and the role of inflammation in this connection. ...In addition, recent evidence reported an i …
OBJECTIVE: The aim of this review is to explore the evidence about the association among celiac disease (CD), atherosclerosis (AS) an …
Varying Definitions of Carotid Intima-Media Thickness and Future Cardiovascular Disease: A Systematic Review and Meta-Analysis.
Ling Y, Wan Y, Barinas-Mitchell E, Fujiyoshi A, Cui H, Maimaiti A, Xu R, Li J, Suo C, Zaid M. Ling Y, et al. J Am Heart Assoc. 2023 Dec 5;12(23):e031217. doi: 10.1161/JAHA.123.031217. Epub 2023 Nov 28. J Am Heart Assoc. 2023. PMID: 38014663 Free PMC article.
BACKGROUND: Carotid intima-media thickness (cIMT) has been widely used as a predictor of future cardiovascular disease (CVD); however, various definitions of cIMT exist. ...The relationships between cIMT of different definitions (common carotid artery …
BACKGROUND: Carotid intima-media thickness (cIMT) has been widely used as a predictor of future cardiovascular d …
A Review on Joint Carotid Intima-Media Thickness and Plaque Area Measurement in Ultrasound for Cardiovascular/Stroke Risk Monitoring: Artificial Intelligence Framework.
Biswas M, Saba L, Omerzu T, Johri AM, Khanna NN, Viskovic K, Mavrogeni S, Laird JR, Pareek G, Miner M, Balestrieri A, Sfikakis PP, Protogerou A, Misra DP, Agarwal V, Kitas GD, Kolluri R, Sharma A, Viswanathan V, Ruzsa Z, Nicolaides A, Suri JS. Biswas M, et al. J Digit Imaging. 2021 Jun;34(3):581-604. doi: 10.1007/s10278-021-00461-2. Epub 2021 Jun 2. J Digit Imaging. 2021. PMID: 34080104 Free PMC article. Review.
Atherosclerosis disease in the arteries is the main cause of the CVD, leading to myocardial infarction and stroke. The two primary image-based phenotypes used for monitoring the atherosclerosis burden is carotid intima-media thickness …
Atherosclerosis disease in the arteries is the main cause of the CVD, leading to myocardial infarction and stroke. The …
Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis.
Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Lorenz MW, et al. Circulation. 2007 Jan 30;115(4):459-67. doi: 10.1161/CIRCULATIONAHA.106.628875. Epub 2007 Jan 22. Circulation. 2007. PMID: 17242284 Review.
BACKGROUND: Carotid intima-media thickness (IMT) is increasingly used as a surrogate marker for atherosclerosis. ...The relative risk per IMT difference is slightly higher for the end point stroke than for myocardial infarction. In future …
BACKGROUND: Carotid intima-media thickness (IMT) is increasingly used as a surrogate marker for atherosclerosis. …
Carotid intima media thickness and blood biomarkers of atherosclerosis in patients after stroke or myocardial infarction.
Kurkowska-Jastrzebska I, Karlinski MA, Błazejewska-Hyzorek B, Sarzynska-Dlugosz I, Filipiak KJ, Czlonkowska A. Kurkowska-Jastrzebska I, et al. Croat Med J. 2016 Dec 31;57(6):548-557. doi: 10.3325/cmj.2016.57.548. Croat Med J. 2016. PMID: 28051279 Free PMC article.
AIM: To test if circulating levels of markers of inflammation, endothelial function, and chronic infections, as well as association between these markers and carotid intima media thickness (CIMT), depend on the stage of atherosclerosis expressed as a h …
AIM: To test if circulating levels of markers of inflammation, endothelial function, and chronic infections, as well as association between …
Autoantibodies against the chemokine receptor 3 predict cardiovascular risk.
Müller FS, Aherrahrou Z, Grasshoff H, Heidorn MW, Humrich JY, Johanson L, Aherrahrou R, Reinberger T, Schulz A, Ten Cate V, Robles AP, Koeck T, Rapp S, Lange T, Brachaczek L, Luebber F, Erdmann J, Heidecke H, Schulze-Forster K, Dechend R, Lackner KJ, Pfeiffer N, Ghaemi Kerahrodi J, Tüscher O, Schwarting A, Strauch K, Münzel T, Prochaska JH, Riemekasten G, Wild PS. Müller FS, et al. Eur Heart J. 2023 Dec 14;44(47):4935-4949. doi: 10.1093/eurheartj/ehad666. Eur Heart J. 2023. PMID: 37941454 Free PMC article.
Regression analyses were carried out to identify determinants of anti-CXCR3 aAbs and relevance for clinical outcome (i.e. all-cause mortality, cardiac death, heart failure, and major adverse cardiac events comprising incident coronary artery disease, myocardial infarcti …
Regression analyses were carried out to identify determinants of anti-CXCR3 aAbs and relevance for clinical outcome (i.e. all-cause mortalit …
Cardiovascular risk and testosterone - from subclinical atherosclerosis to lipoprotein function to heart failure.
Gencer B, Bonomi M, Adorni MP, Sirtori CR, Mach F, Ruscica M. Gencer B, et al. Rev Endocr Metab Disord. 2021 Jun;22(2):257-274. doi: 10.1007/s11154-021-09628-2. Epub 2021 Feb 22. Rev Endocr Metab Disord. 2021. PMID: 33616800 Free PMC article. Review.
The cardiovascular (CV) benefit and safety of treating low testosterone conditions is a matter of debate. Although testosterone deficiency has been linked to a rise in major adverse CV events, most of the studies on testosterone replacement therapy were not designed to ass …
The cardiovascular (CV) benefit and safety of treating low testosterone conditions is a matter of debate. Although testosterone defic …
407 results